Insulin degludec 100 U/mL for treatment of spontaneous diabetes mellitus in dogs
Insulin degludec 100 U/mL for treatment of spontaneous diabetes mellitus in dogs
About this item
Full title
Author / Creator
Publisher
Hoboken, USA: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Hoboken, USA: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Background
The advantages of insulin degludec 100 U/mL (IDeg100) in the treatment of diabetes mellitus (DM) include consistent release, predictable glucose‐lowering effect, and minimal day‐to‐day variability.
Hypothesis/Objectives
To describe the use of IDeg100 in dogs with DM, level of diabetic control and adverse effects.
Animals
T...
Alternative Titles
Full title
Insulin degludec 100 U/mL for treatment of spontaneous diabetes mellitus in dogs
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_87bb6c82e859450cb83bd7cef06593d6
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_87bb6c82e859450cb83bd7cef06593d6
Other Identifiers
ISSN
0891-6640,1939-1676
E-ISSN
1939-1676
DOI
10.1111/jvim.17303
